
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 1.260 | 1.380 | 0.120 |
Shares | 98.690 | 98.690 | 0.000 |
Bonds | 0.050 | 0.050 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.298 | 18.741 |
Price to Book | 2.973 | 3.072 |
Price to Sales | 1.710 | 2.284 |
Price to Cash Flow | 12.104 | 12.188 |
Dividend Yield | 1.522 | 2.038 |
5 Years Earnings Growth | 13.061 | 9.709 |
Name | Net % | Category Average |
---|---|---|
Technology | 24.290 | 24.539 |
Financial Services | 18.320 | 16.878 |
Healthcare | 16.510 | 12.057 |
Consumer Cyclical | 12.270 | 10.309 |
Industrials | 12.060 | 12.127 |
Communication Services | 6.860 | 8.148 |
Energy | 3.870 | 3.331 |
Utilities | 3.430 | 2.533 |
Basic Materials | 1.940 | 3.933 |
Real Estate | 0.460 | 2.760 |
Number of long holdings: 250
Number of short holdings: 4
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 6.17 | 506.09 | +0.81% | |
Amazon.com | US0231351067 | 4.45 | 228.94 | +0.10% | |
Alphabet A | US02079K3059 | 3.75 | 207.27 | +0.06% | |
JPMorgan | US46625H1005 | 2.92 | 299.75 | +0.40% | |
Meta Platforms | US30303M1027 | 2.25 | 746.69 | -0.98% | |
Mastercard | US57636Q1040 | 2.20 | 590.36 | -0.21% | |
Marvell | US5738741041 | 2.11 | 74.87 | +0.82% | |
AstraZeneca | GB0009895292 | 2.09 | 11,876.0 | +0.03% | |
UnitedHealth | US91324P1021 | 2.02 | 304.31 | +1.29% | |
NVIDIA | US67066G1040 | 1.98 | 181.81 | +0.02% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Global Dividend Fund A MINCOME G HK | 17.92B | 17.11 | 14.14 | 7.87 | ||
Fidelity China Consumer A Acc HKD | 399.29M | 21.01 | -1.11 | 0.93 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review